Skip to main content

Table 3 Molecular subtyping shifts of 34 breast cancer patients

From: Is it sufficient to evaluate metastatic bone involvement in breast cancer using SPECT/CT? A new approach of SPECT/CT-guided targeted bone marrow biopsy

Molecular subtype shifts

datum

%

Unchanged

19

55.8

Changed

16

47.0

Total

34

100